Lemoucheux et al.
SCHEME 1a
give access in short time and high yield to radioactive
11C- or 14C-probes.
Pharmaceutically active molecules often contain ureas,
carbamates, or related functions. In stable isotope chem-
istry, carbamoyl chlorides are common intermediates for
the introduction of these functional groups.4 Moreover,
they can also be transformed into amides by reaction with
aryllithiums.5 Recently, we have developed their nickel-
catalyzed cross-coupling reactions with Grignard re-
agents as an alternative route to amides.6 Carbamoyl
chlorides are often synthesized by reaction of a secondary
amine with an excess of phosgene.7 These conditions are
detrimental to the environment, and they cannot be used
under radioactive conditions. Moreover, they often lead
to byproducts. The pallado-catalyzed carbonylation of
chloramines8 or selenium-mediated carbonylation of
amines or alcohols9 under carbon monoxide pressure
could be envisaged. However, this possibility was not
considered since it required either a pressure of carbon
monoxide or, in carbon-11 chemistry, a special technol-
ogy.10 Formamides are also direct precursors of carbamoyl
chlorides by reaction with a chlorinating reagent,11 but
their 11C-labeled counterparts have not yet been de-
scribed. Methods based on the use of carbon dioxide and
again a chlorinating agent have been employed both in
14C-carbon12 and 11C-carbon13 chemistries. However, yields
and selectivities remained moderate. [11C]Phosgene, eas-
ily prepared from cyclotron-produced [11C]methane,14
remains the precursor of choice for rapid and efficient
radiosyntheses of symmetrical15 or cyclic 11C-ureas16 and
a
Reagents and conditions: (a) excess COCl2, rt, toluene; (b)
[
11C]COCl2, -78 °C, THF; (c) BTC or COCl2 and NEt3, dichlo-
romethane.
11C-carbamates via the formation of the corresponding
11C-isocyanates under high dilution of the starting amine.17
[11C]Phosgene was used to prepare 11C-labeled ethylchlo-
roformate in low yields,18 [11C]methanol being preferred
for the 11C-labeling of methylchloroformate.19 To our
knowledge, only one 11C-carbamoyl chloride has been
isolated and characterized due to the low reactivity of
the used amine.20 Indeed, if carbamoyl chlorides are the
products formed by reaction of secondary amines and
phosgene under normal conditions,21 11C-ureas are the
only products isolated in 11C-chemistry. Our preliminary
labeling experiments confirmed the difficulty in prepar-
ing 11C-labeled carbamoyl chlorides. The reaction of
tetrahydroisoquinoline 1 or N-benzylpiperazine 4 (1.5
mmol or 15 µmol) in THF or toluene (400 µL) with [11C]-
phosgene was performed at -10 or -78 °C for 5 min.
Radio-TLC or HPLC analyses of the crude reaction
mixture showed the exclusive formation of the corre-
sponding 11C-ureas 3 or 6 (Scheme 1).
(3) For general references on practical PET chemistry, see: (a)
Fowler, J . S., Wolf, A. P. In Positron Emission Tomography and
Autoradiography: Principles and Applications for the Brain and Heart;
Phelps, M., Mazziota, J ., Schelbert, H., Eds.; Raven Press: New York,
1986; Chapter 9. (b) Radiopharmaceuticals for Positron Emission
Tomography: Methodological Aspects; Sto¨cklin, G., Pike, V. W., Eds.;
Kluwer Academic Publishers: Dordrecht, The Netherlands, 1993. (c)
Langstro¨m, B.; Kihlberg, T.; Bergstro¨m, M.; Antoni, G.; Bjo¨rkman, M.;
Forngren, B. H.; Forngren, T.; Hartvig, P.; Markides, K.; Yngve, U.;
O¨ gren, M. Acta Chem. Scand. 1999, 53, 651-669.
(4) Hegarty, A. F. In Comprehensive Organic Chemistry; Sutherland,
I. O., Ed.; Pergamon Press: Oxford, 1979; Vol. 2, Chapter 9.10.
(5) Mills, R. J .; Taylor, N. J .; Snieckus, V. J . Org. Chem. 1989, 54,
4372-4385.
(6) Lemoucheux, L.; Rouden, J .; Lasne, M.-C. Tetrahedron Lett.
2000, 41, 9997-1001.
(7) (a) Holmes, D. L.; Smith, E. M.; Nowick, J . S. J . Am. Chem. Soc.
1997, 119, 7665-7669. (b). Wang, G. T.; Chen, Y.; Wang, S.; Sciotti,
R.; Sowin, T. Tetrahedron Lett. 1997, 38, 1895-1898. (c) Nowick, J .
S.; Holmes, D. L.; Noronha, G.; Smith, E. M.; Nguyen, T. M.; Huang,
S.-L. J . Org. Chem. 1996, 61, 3929-3934.
(8) Saegusa, T.; Tsuda, T.; Isegawa, Y. J . Org. Chem. 1971, 36, 858-
860.
(9) Kihlberg, T.; Karimi, F.; Langstro¨m, B. J . Org. Chem. 2002, 67,
3687-3692.
(10) Karimi, F.; Langstro¨m, B. Org. Biomol. Chem. 2003, 1, 541-
(16) (a) Crouzel, C.; Mestelan, G.; Kraus, E.; Lecomte, J . M.; Comar,
D. Appl. Radiat. Isot. 1980, 31, 545-548. (b) Roeda, D.; Tavitian, B.;
Coulon, C.; David, F.; Dolle´, F.; Fuseau, C.; J obert, A.; Crouzel, C.
Bioorg. Med. Chem. 1997, 5, 397-403. (c) Hammadi, A.; Crouzel, C.
J . Labelled Compd. Radiopharm. 1991, 29, 681-689.
(17) (a) Dolle´, F.; Valette, H.; Hinnen, F.; Vaufrey, F.; Demphel, S.;
Coulon, C.; Ottaviani, M.; Bottlaender, M.; Crouzel, C. J . Labelled
Compd. Radiopharm. 2001, 44, 785-795. (b) Crouzel, C.; Hinnen, F.;
Maitre, E. Appl. Radiat. Isot. 1995, 46, 167-170. (c) Conway, T.; Diksic,
M. J . Nucl. Med. 1988, 29, 1957-1960.
(18) Rousseau, A. H.; Diksic, M.; Van Lier, J . E. Int. J . Appl.
Instrum. B 1992, 19, 175.
(19) Ravert, H. T.; Mathews, W. B.; Musachoio, J . L.; Dannals, R.
F. J . Labelled Compd. Radiopharm. 1995, 36, 365-371.
(20) Lasne, M.-C.; Barre´, L.; Huard, C.; Ducandas, C.; McKenzie,
E. T. J . Labelled Compd. Radiopharm. 1993, 38, 425-426.
(21) Gymer, G. E.; Narayanaswani, S. N. In Comprehensive Organic
Functional Group Transformations; Katritzky, A. R., Meth-Cohn, O.,
Rees, C. W., Eds.; Pergamon Press: Oxford, 1995; Vol. 6, p 443.
546 and references therein.
(11) (a) Schindler, N.; Plo¨ger, W. Chem Ber. 1971, 104, 969-971.
(b) Hasserodt, U. Chem Ber 1968, 101, 113-120.
(12) (a) Volford, J .; Knausz, D.; Meszticzky, A.; Horvath, L.; Csak-
vari, B. J . Labelled Compd. Radiopharm. 1981, 18, 555. (b) Hoshino,
O.; Saito, K.; Ishizaki, M.; Umezawa, B. Synth. Commun. 1987, 17,
1887-1892. (c) Birkofer, L.; Krebs, K. Tetrahedron Lett. 1968, 885-
888. (d) Dean, D. C.; Wallace, M. A.; Marks, T. N.; Melillo, D. G.
Tetrahedron Lett. 1997, 38, 919-922.
(13) Schirbel, A.; Holschbach, M. H.; Coenen, H. H. J . Labelled
Compd. Radiopharm. 1999, 42, 537-551.
(14) (a) Landais, P.; Crouzel, C. Appl. Radiat. Isot. 1987, 38, 297-
300. (b) Link, J . M.; Krohn, K. A J . Labelled Compd. Radiopharm.
1997, 40, 306-308.
(15) (a) Lidstro¨m, P.; Bonasera, T. A.; Marquez-M, M.; Nilsson, S.;
Bergstro¨m, M.; Langstro¨m, B. Steroids 1998, 63, 228-234. (b) Lid-
stro¨m, P.; Bonasera, T. A.; Nilsson, S.; Langstro¨m, B. J . Labelled
Compd. Radiopharm. 1997, 40, 788-789.
7290 J . Org. Chem., Vol. 68, No. 19, 2003